Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
OsteoarthritisPain
Interventions
DRUG

Placebo Gel

6 mL of Placebo Gel administered TID for 6 weeks

DRUG

OLT1177 Gel

6 mL of OLT1177 Gel (5%) administered TID for 6 weeks

Trial Locations (13)

22911

Charlottesville Medical Research Center, LLC, Charlottesville

29406

Clinical Trials of South Carolina, Charleston

29464

Coastal Carolina Research Center, Inc, Mt. Pleasant

32720

Avail Clinical Research, DeLand

32771

International Clinical Research - US, LLC, Sanford

33143

Miami Research Associates, LLC, South Miami

33319

Sunrise Medical Research, Inc., Lauderdale Lakes

33458

Health Awareness, Inc., Jupiter

35216

Achieve Clinical Research, LLC, Birmingham

63042

Healthcare Research Network, Inc., Hazelwood

70115

Best Clinical Trial, LLC, New Orleans

06460

Clinical Research Consulting, LLC, Milford

02886

Omega Medical Research, Warwick

Sponsors
All Listed Sponsors
lead

Olatec Therapeutics LLC

INDUSTRY